Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The main objective of this study is to assess the safety and effectiveness of the Edwards Lifesciences LifeStent nitinol self expandable stent device and its delivery system in the treatment of occlusive superficial femoral artery (SFA) disease by reducing the re-intervention rate as compared to percutaneous transluminal angioplasty (PTA) alone
Epistemonikos ID: b500d058a1519c93b47cf27f1ddd4ded2c1f7baa
First added on: May 05, 2024